Lowe J G, Beck J S, Gibbs J H, Brown R A, Potts R C, Grange J M, Stanford J L
J Clin Pathol. 1987 Jan;40(1):42-9. doi: 10.1136/jcp.40.1.42.
The response to skin testing with tuberculins extracted from various species of mycobacteria was studied in 49 patients from Dundee with chronic obstructive airways disease. Seventeen had never been treated with steroids (group 1), 17 were receiving short term high doses of prednisolone (group 2) and did not have impaired Synacthen tests; 15 were receiving long term maintenance treatment and did have impaired Synacthen tests (group 3). Erythematous and indurated reactions were seen in a few patients, more commonly to antigens from Mycobacterium tuberculosis than to the other species: neither of the latter treatment groups showed appreciable reduction in reactivity compared with that of the group 1 patients. The number and microanatomical distribution of the T4 and T8 lymphocytes and the M3 bearing monocytes and macrophages was studied immunocytochemically in cryostat sections of biopsy specimens from the antigen injection sites. The density of these cells was significantly less in clinically negative reactions than in those with erythema or induration, but was unrelated to the presence or absence of a history of treatment with prednisolone. The T4:T8 ratio in the section as a whole was similar to that of the peripheral blood, but T8 cells were relatively more common in the perivascular and periappendicular foci, and T4 lymphocytes were predominant in the diffuse component of the infiltrate. I12 receptor bearing lymphocytes were uncommon: such cells were least common in the clinically negative reactions, but the number and distribution were apparently unrelated to the presence or absence of prednisolone treatment. It was concluded that currently accepted regimens of treatment with prednisolone did not reduce the effector arm of type IV (delayed type hypersensitivity) responses and so are unlikely to compromise this aspect of protective immunity.
对49名来自邓迪患有慢性阻塞性气道疾病的患者进行了研究,观察他们对从各种分枝杆菌物种中提取的结核菌素进行皮肤试验的反应。17名患者从未接受过类固醇治疗(第1组),17名患者正在接受短期高剂量泼尼松龙治疗(第2组)且促肾上腺皮质激素试验未受损;15名患者正在接受长期维持治疗且促肾上腺皮质激素试验受损(第3组)。少数患者出现红斑和硬结反应,对结核分枝杆菌抗原的反应比其他物种更常见:与第1组患者相比,后两个治疗组的反应性均未出现明显降低。在抗原注射部位活检标本的低温切片中,采用免疫细胞化学方法研究了T4和T8淋巴细胞以及携带M3的单核细胞和巨噬细胞的数量和微解剖分布。这些细胞的密度在临床阴性反应中明显低于有红斑或硬结的反应,但与是否有泼尼松龙治疗史无关。切片整体的T4:T8比值与外周血相似,但T8细胞在血管周围和腺周围灶中相对更常见,而T4淋巴细胞在浸润的弥漫成分中占主导。携带白细胞介素12受体的淋巴细胞不常见:此类细胞在临床阴性反应中最少见,但数量和分布显然与是否接受泼尼松龙治疗无关。得出的结论是,目前公认的泼尼松龙治疗方案不会降低IV型(迟发型超敏反应)反应的效应臂,因此不太可能损害保护性免疫的这一方面。